Day One Biopharmaceuticals's total assets for Q3 2025 were $513.78M, a decrease of -1.01% from the previous quarter. DAWN total liabilities were $62.91M for the fiscal quarter, a 8.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.